Amarantus Appoints Michael T. Ropacki, PhD as Chief Medical Advisor for Alzheimer's Blood Diagnostic LymPro Test Program
April 16, 2018 07:31 ET
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company...
Amarantus Re-acquires Rights to Alzheimer's Blood Diagnostic LymPro Test
April 06, 2018 11:24 ET
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, April 06, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company...